As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Featured Blog - Suggestions in improving the transition from pediatric to adult care in patients with type 1 diabetes
The period when teens with type 1 diabetes transition from pediatric to adult care is critical, which can result in these adolescents being at heightened risk for poor glycemic control in addition to the other challenges young adulthood brings. A recently published review in Clinical Diabetes and Endocrinology explores these challenges and offers new recommendations on how patients and endocrinologists can navigate this difficult process.
by Kathryn Rodeman & Inas Thomas 29 May 2019
Atypical hyperglycemia presentation suggests considering a diagnostic of other types of diabetes: first reported GCK-MODY in Perú
Featured article: Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports
Since 2011 six immune checkpoint inhibitors (ICI) have been approved to treat patients with many advanced solid tumor and hematological malignancies to improve their prognosis. Case reports of their endocrine immune-related adverse events) are increasingly published as more real-world patients with these malignancies are treated with these drugs. Tan et al conduct a scoping review of the spectrum and characteristics of ICI-induced endocrinopathies case reports before and after ICIs are marketed. by M. H. Tan, et al
Aims and Scope
Clinical Diabetes and Endocrinology is an open access journal publishing within the field of diabetes and endocrine disease. The journal aims to provide a widely available resource for people working within the field of diabetes and endocrinology, in order to improve the care of people affected by these conditions.
The audience includes, but is not limited to, physicians, researchers, nurses, nutritionists, pharmacists, podiatrists, psychologists, epidemiologists, exercise physiologists and health care researchers.
Research articles include patient-based research, translational research, as well as epidemiology and health care research. Clinical articles include case reports, case seminars, consensus statements, clinical practice guidelines and evidence-based medicine.
We are pleased to announce that all articles published in Clinical Diabetes and Endocrinology are included in PubMed and PubMed Central.
Sign up to receive article alerts
Clinical Diabetes and Endocrinology is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering Sign up for article alerts and news from this journal .
Welcome New Editors-in-Chief
Welcome Dr. Ariel Barkan and Dr. Roma Gianchandani, the new Editors-in-Chief of Clinical Diabetes & Endocrinology
Quote from Editor Emeritus
"Clinical Diabetes and Endocrinology aims to promote better care by health professionals for people with diabetes and endocrine disease, by sharing with them new research and clinical knowledge on various aspects of the disease and its management.
New knowledge about diseases and their management should be readily and freely accessible to health professionals worldwide to have global impact. To achieve this goal, Clinical Diabetes and Endocrinology is an open-access, online journal. Our distinguished, international, Editorial Board comprises of experts from 19 nations and 5 continents bringing a wealth of knowledge and experience from across the globe.
Clinical Diabetes and Endocrinology intends to enable our authors to share their newly uncovered knowledge with health professionals around the world who will use this new knowledge to promote better care for people with diabetes and endocrine diseases."
Prof Meng Tan, Editor Emeritus, Clinical Diabetes and Endocrinology
Clinical Diabetes and Endocrinology is published in collaboration with the University of Michigan. Authors affiliated with the University of Michigan receive a 15% discount on APC costs.
Annual Journal Metrics
57 days to first decision for reviewed manuscripts only
39 days to first decision for all manuscripts
128 days from submission to acceptance
22 days from acceptance to publication
24 Altmetric mentions